Drug Shortage Report for FUNGIZONE
| Report ID | 221737 |
| Drug Identification Number | 00029149 |
| Brand name | FUNGIZONE |
| Common or Proper name | amphotericin B for Injection |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | AMPHOTERICIN B |
| Strength(s) | 50MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50 mg/vial |
| ATC code | J02AA |
| ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-03-11 |
| Actual start date | |
| Estimated end date | 2024-05-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-03-12 | English | Compare |
| v2 | 2024-03-08 | French | Compare |
| v1 | 2024-03-08 | English | Compare |
Showing 1 to 3 of 3